Receptors

Introduction to Receptors

Receptors are specialized proteins, most often located on the plasma membrane but sometimes inside the cell, that detect external signals and convert them into cellular responses. These signals—or ligands—include hormones, neurotransmitters, growth factors, paracrine signals, and even pharmaceutical drugs.

When a ligand binds its receptor, it triggers a signal transduction cascade:

Reception – ligand binding.
Transduction – activation of intracellular pathways, often involving enzymes and second messengers.
Response – a physiological change, such as altered metabolism, secretion, contraction, or gene expression.
Termination – deactivation of the signal to reset the system.

This process ensures that cells can detect changes in their environment and respond in ways that preserve homeostasis, regulate growth, and coordinate bodily functions. Many drugs target receptors (e.g., beta-blockers at adrenergic receptors), making receptor biology central to pharmacology.

Major Classes of Receptors

Ion Channel–Linked Receptors (Ionotropic Receptors)

Structure: Multisubunit proteins forming a pore across the plasma membrane.
Activation: Ligand binding induces a conformational change that opens or closes the ion channel.
Speed: Very rapid (milliseconds).
Outcome: Ions flow down their electrochemical gradients, altering the membrane potential and triggering an action potential or immediate response.

Example: The nicotinic acetylcholine receptor at the neuromuscular junction. Binding of acetylcholine opens Na⁺ channels, depolarizing the muscle membrane and initiating contraction.

Clinical relevance:

Nicotinic receptor blockers (e.g., curare) cause paralysis.
Excessive activation by toxins (e.g., nicotine or black widow spider venom) leads to overstimulation and muscle spasms.

G Protein–Coupled Receptors (GPCRs)

GPCRs form the largest receptor family in humans, with ~800 genes encoding them. About one-third of all drugs act on GPCRs.

Structure:

Seven transmembrane (7TM) α-helices connected by extracellular and intracellular loops.
Extracellular domain binds ligand; intracellular domain interacts with heterotrimeric G-proteins.

Mechanism:

Ligand binds the GPCR.
The associated G-protein exchanges GDP for GTP on its α-subunit.
The α-subunit separates from the βγ dimer and interacts with target enzymes or channels.
Enzymes produce second messengers (cAMP, IP₃, DAG, Ca²⁺).
Second messengers amplify the signal and activate kinases (PKA, PKC, CaM-kinases).
Cellular proteins are phosphorylated, altering activity.

Key pathways:

Gs pathway: Stimulates adenylyl cyclase → ↑ cAMP → activates protein kinase A → ↑ metabolism, ↑ heart rate.
Gi pathway: Inhibits adenylyl cyclase → ↓ cAMP → dampens cellular activity.
Gq pathway: Activates phospholipase C → PIP₂ split into DAG + IP₃.
- DAG + Ca²⁺ activate protein kinase C.
- IP₃ releases Ca²⁺ from the ER, activating calmodulin-dependent kinases.

Examples:

Adrenergic receptors (epinephrine/norepinephrine): regulate fight-or-flight responses.
Muscarinic acetylcholine receptors: regulate smooth muscle and glandular activity.
Olfactory and visual receptors: detect light and odors.

Clinical relevance:

Beta-blockers act on β-adrenergic GPCRs to lower blood pressure.
Antihistamines block histamine GPCRs to reduce allergic reactions.
Opioids (morphine, fentanyl) bind GPCRs, but prolonged use causes desensitization and tolerance.

Enzyme-Linked Receptors

These are membrane receptors with intrinsic enzymatic activity or tightly associated enzymes.

Most common type: Receptor Tyrosine Kinases (RTKs).

Mechanism:
1. Ligand binding → receptor dimerization.
2. Autophosphorylation of tyrosine residues.
3. Recruitment of intracellular signaling proteins.
4. Activation of downstream pathways such as MAP kinase and PI3K/Akt.
Example: The insulin receptor, which regulates glucose uptake by stimulating translocation of GLUT4 transporters.

Other examples: Receptor serine/threonine kinases (e.g., TGF-β receptor), receptor guanylyl cyclases (e.g., ANP receptor).

Clinical relevance:

Overactive RTKs contribute to cancer (e.g., HER2 receptor in breast cancer).
Targeted therapies like trastuzumab (Herceptin) block overactive RTKs.

Intracellular (Nuclear) Receptors

These receptors are located in the cytoplasm or nucleus. Ligands must be lipid-soluble to cross the plasma membrane.

Ligands: Steroid hormones (cortisol, estrogen, testosterone), thyroid hormones, vitamin D, retinoic acid.
Mechanism:
1. Ligand enters the cell and binds receptor.
2. The receptor-ligand complex translocates to the nucleus.
3. It binds DNA at hormone response elements.
4. Alters transcription of specific genes.
Response speed: Slow (hours to days).
Outcome: Long-lasting effects on development, metabolism, and differentiation.

Clinical relevance:

Cortisol receptors regulate stress responses and inflammation.
Estrogen receptors are targeted in breast cancer therapy with tamoxifen.

Nuclear receptor | PPTX | Endocrine and Metabolic Diseases | Diseases ...

Signal Amplification

A hallmark of receptor signaling is amplification. A single ligand-receptor binding event can activate multiple G-proteins, each stimulating an enzyme to generate thousands of second messenger molecules. Each second messenger activates many protein kinases, which phosphorylate hundreds of target proteins.

This exponential amplification means that cells can respond strongly to very low concentrations of ligands.

PPT - Chapter 11: Cell Communication PowerPoint Presentation, free ...

Second Messengers

cAMP → activates protein kinase A.
IP₃ → releases Ca²⁺ from ER.
DAG → activates protein kinase C.
Ca²⁺ → activates calmodulin, which stimulates CaM-kinases.

These molecules are short-lived but powerful, ensuring rapid yet controllable responses.

Receptor Desensitization

Cells must avoid overstimulation. Prolonged receptor activation leads to desensitization via several mechanisms:

Receptor phosphorylation (uncouples receptor from G-protein).
Receptor internalization (endocytosis).
Downregulation of receptor synthesis.

Examples:

Chronic morphine use → opioid receptor desensitization → tolerance.
Chronic hyperinsulinemia → insulin receptor resistance → type 2 diabetes mellitus.

Physiological Relevance

Neurotransmission: Ionotropic acetylcholine receptors mediate rapid synaptic transmission.
Endocrine regulation: Insulin receptor (RTK) maintains glucose balance.
Stress response: Adrenergic GPCRs orchestrate fight-or-flight effects.
Homeostasis: GPCRs regulate blood pressure, heart rate, and metabolism.